Today's pre-market stock movers: FDX, REV, BCS, KMX and more
Gainers:
• $Ballys(BALY.US$ +6% (announces modified "Dutch auction" tender offer to purchase shares at $19.25-$22)
• $Ferguson(FERG.US$ +3.4% (enters entered into a non-discretionary arrangement with its brokers J.P. Morgan Securities in continuation of its $2 billion share repurchase program)
• $Sanofi(SNY.US$ +3.2% (Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine)
• $Emergent BioSolutions(EBS.US$ +3.1% (receives FDA Acceptance of BLA for AV7909 Anthrax vaccine candidate)
• $Intellia Therapeutics(NTLA.US$ +2.4% (Intellia Therapeutics and Regeneron Pharmaceuticals (REGN) announce additional "positive" interim data from an ongoing Phase 1 study of their lead investigational in vivo genome editing candidate NTLA-2001)
• $Biomarin Pharmaceutical(BMRN.US$ +2.3% (confirms that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional marketing authorization for its investigational gene therapy valoctocogene roxaparvovec for adults with severe hemophilia A)
• $Takeda Pharmaceutical(TAK.US$ +1.9% (to succeed to the rights and obligations relating to Plasma-Derived Therapies and all other businesses of Nihon through an absorption-type company split)
• $Novartis AG(NVS.US$ +1.8% (receives positive CHMP opinion for Scemblix a novel treatment for adult patients with chronic myeloid leukemia)
• $GlaxoSmithKline(GSK.US$ +1.1% (Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine)
• $Petroleo Brasileiro SA Petrobras(PBR.US$ +1.1% (approved the sale of its total stake in the maritime concessions groups named Golfinho Cluster and Camarupim Cluster)
Analyst comments:
Losers:
• $Revlon(REV.US$ -5.7% (discloses that a portion of the proceeds of the initial borrowing under the DIP Term Loan Facility were used to repay in full and terminate the Foreign ABL Credit Agreement)
• $Sarepta Therapeutics(SRPT.US$ -0.5% (FDA places clinical hold on SRP-5051 for Duchenne muscular dystrophy)
Analyst comments:
• $Baxter International Inc(BAX.US$ -1.7% (downgraded to Equal Weight from Overweight at Wells Fargo)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
imaginative Sheep_70 :